In this session...
By the year 2024, the cannabis and CBD markets are estimated to reach a value of $20 billion! Today, over 20 countries have already legalized medical marijuana and 64 million Americans have tried cannabidiol or CBD products. Ready or not, the cannabinoid and cannabis markets have officially exploded and will only continue to grow. Rob Dhoble, Managing Director of Havas ECS, explains this rapidly expanding and dynamic market, the massive gaps that exist in education and use, and what it means for the future of health care.
What You'll Learn from This Session...
- An overview of the science of the endocannabinoid system and its importance to human function
- Current and future trends in the cannabis, cannabinoid, and CBD markets
- Tackling the gaps in education between patients, physicians, HCPs, and more - what you need to know and why
- The future of health care in relation to cannabis use
NewGen